The aminocoumarin antibiotic clorobiocin contains a 5-methylpyrrole-2-carboxylic acid unit, attached via an ester bond to the 3-OH group of the deoxysugar moiety. To investigate candidate genes responsible for the formation of this ester bond, a gene inactivation experiment was carried out in the clorobiocin producer Streptomyces roseochromogenes var. oscitans DS 12.976. An in-frame deletion was created in the coding sequence of the gene cloN2. The production of secondary metabolites in the wild-type and in the cloN2 mutant was analysed. The wild-type showed clorobiocin as the main product, whereas the cloN2 mutant accumulated a new aminocoumarin derivative, novclobiocin 104, lacking the pyrrole moiety at the 3-OH of the deoxysugar. In addition, free pyrrole-2-carboxylic acid accumulated in the culture extract of the cloN2 mutant. The structures of the metabolites were confirmed by NMR and LC-MS analysis. Clorobiocin production was successfully restored in the cloN2 mutant by introducing a replicative plasmid containing the cloN2 sequence. These results prove an involvement of cloN2 in the formation of the ester bond between the pyrrole moiety and the deoxysugar in clorobiocin biosynthesis. Furthermore, they indicate that the C-methylation at position 5 of the pyrrole moiety occurs after the attachment of pyrrole-2-carboxylic acid unit to the deoxysugar moiety.
INTRODUCTION
The structurally related aminocoumarin antibiotics clorobiocin, novobiocin and coumermycin A 1 (Fig. 1 ) are potent DNA gyrase B inhibitors (Maxwell & Lawson, 2003) . Clorobiocin is more active against Gram-positive bacteria than novobiocin (Berger & Batcho, 1978) and shows much better solubility in water as well as in organic reagents than coumermycin A 1 . This makes clorobiocin a very interesting starting material for the development of new antibacterial compounds.
Recently, our group has identified the biosynthetic gene clusters for novobiocin from Streptomyces spheroides NCIMB 11891 (Steffensky et al., 2000) , for coumermycin A 1 from Streptomyces rishiriensis DSM 40489 and for clorobiocin from Streptomyces roseochromogenes var. oscitans DS 12.976 (Pojer et al., 2002) . A comparison of these gene clusters showed that the structural differences and similarities between the three antibiotics are reflected perfectly by the differences and similarities in the organization of the corresponding biosynthetic gene clusters (Pojer et al., 2002) .
Structurally, both clorobiocin and coumermycin A 1 have a 5-methylpyrrole-2-carboxyl moiety attached to the 3-OH of the deoxysugar moiety, while novobiocin contains a carbamoyl group at the corresponding position. The novobiocin gene cluster contains a carbamoyltransferase gene, novN. At the same relative position, a group of seven genes, cloN1 to cloN7 and the homologous couN1 to couN7, are found in the gene clusters of clorobiocin and coumermycin A 1 , respectively (Pojer et al., 2002) . Our earlier study (Xu et al., 2002) showed that couN3 and couN4 are involved in the biosynthesis of the pyrrole-2-carboxylic acid in coumermycin A 1 . Pyoluterin and undecylprodigiosin also contain pyrrole-2-carboxylic acid moieties, and in their biosynthesis the intermediate pyrrole-2-carboxyl-S-[peptidyl carrier protein] is formed from L-proline by the enzymes PltE, PltF and PltL (pyoluteorin) and RedW, RedM and RedO (undecylprodigiosin) , respectively (Cerdeno et al., 2001; Thomas et al., 2002; Xu et al., 2002) . CloN3, CloN4 and CloN5, encoded by genes of the clorobiocin gene cluster, show high sequence similarity to PltE/F/L and RedW/M/O, respectively, and are therefore likely to convert L-proline to a pyrrole-2-carboxyl-S-PCP intermediate as well. A similar function is expected for their homologues in the coumermycin biosynthetic gene cluster, i.e. couN3, couN4 and couN5.
Little is known about the transfer of the pyrrole-2-carboxyl moiety to the deoxysugar of clorobiocin or coumermycin A 1 . No genes with similarity to acyltransferases involved in the biosynthesis of acylated sugar moieties were found in the clorobiocin or coumermycin A 1 biosynthetic gene clusters.
The gene cloN2, immediately upstream of cloN3, shows homology to genes which have been proposed to be involved in orsellenic acid biosynthesis. We provide here evidence for the involvement of cloN2 in the transfer of pyrrole-2-carboxylic acid to the deoxysugar moiety in clorobiocin biosynthesis of S. roseochromogenes.
METHODS
Bacterial strains and culture conditions. The composition of the media and the culture conditions used for S. roseochromogenes var. oscitans DS 12.976 (Aventis) were as described previously (Pojer et al., 2002) . For isolation of chromosomal DNA and preparation of protoplasts, S. roseochromogenes was grown in CRM medium containing 0?75 % glycine. For the production of clorobiocin and other secondary metabolites, wild-type and mutant strains of S. roseochromogenes were cultured in production medium containing distiller solubles (Mancy et al., 1974; Pojer et al., 2002) .
Escherichia coli XL-1 Blue MRF9 (Stratagene) was used for the preparation of recombinant plasmids. The DNA-methylase-negative strain E. coli ET 12567 (MacNeil et al., 1992) was used to propagate plasmids for transformation in Streptomyces.
Carbenicillin (50 mg ml 21 for E. coli) and thiostrepton (50 mg ml 21 for S. roseochromogenes) were used for selection.
Genetic procedures. Standard methods for DNA isolation and manipulation were performed as described elsewhere (Kieser et al., 2000; Sambrook & Russell, 2001) . DNA fragments were isolated from agarose gels using a NucleoSpin 2 in 1 extraction kit (Macherey-Nagel) according to the manufacturer's protocol. Plasmids were isolated from E. coli with ion-exchange columns (Nucleobond AX, Macherey-Nagel). Plasmids were isolated from Streptomyces as described by Kieser et al. (2000) .
Southern blot analysis was performed on Hybond-N membranes (Amersham Biosciences) with a digoxigenin-labelled probe by using the DIG high prime DNA labelling and detection kit II (Roche Applied Science).
Construction of vector pN2 for gene inactivation. Vector pN2 was constructed for in-frame deletion of cloN2 as follows. Two fragments, cloN2-1 and cloN2-2, containing the flanking regions of cloN2, were generated by PCR amplification using cosmid K1F2 as template. Primer pairs used were cloN2-1/XbaI (59-TTG ACC CGG TCT AGA TGT TCA GAC-39) and cloN2-1/NotI (59-CTC CGA TCG CGG CCG CGT ATA TAC-39); cloN2-2/NotI (59-CAT ACA AGG CGG CCG CCA TCC GAA-39) and cloN2-2/HindIII (59-GCA GTA GGA AAG CTT GGT TGG TCA-39). The letters shown in bold represent the mutations inserted in the original sequence to give desired restriction sites (underlined).
The PCR fragments of cloN2-1 and cloN2-2 were purified and ligated into the linearized vector pGEM-T (Promega), to give plasmids pN21 and pN22, respectively. The 1276 bp NotI-HindIII fragment (bp 22151-23426 in sequence AF329398) was excised from pN22 and cloned into the same sites of pcDNA 2.1 (Invitrogen) to give plasmid pN23. The XbaI-NotI fragment of 1308 bp (bp 19866-21173 in sequence AF329398) was isolated from plasmid pN21 and ligated into the same sites of pN23, resulting in plasmid pN24, which contained an in-frame deletion of 978 bp in the coding region of cloN2. The inactivation vector pN2 was obtained by releasing the XbaI-HindIII fragment of 2584 bp from pN24 and cloned into the same sites of pBSKT (Lombo et al., 1997) , a non-replicative vector containing a thiostrepton-resistance gene.
Transformation of S. roseochromogenes and selection of recombinant mutant. S. roseochromogenes protoplast preparation, transformation and regeneration were carried out by a modification of the method described by Pojer et al. (2002) , using 40 % polyethylene glycol (PEG) 1000 (Merck) instead of 50 %. After 20-24 h of incubation at 30 uC, the plates were overlaid with 3 ml soft nutrient agar (Kieser et al., 2000) containing a total of 0?5 mg thiostrepton for selection of integration mutants.
After transforming S. roseochromogenes protoplasts with plasmid pN2, thiostrepton-resistant colonies were obtained. The single-crossover mutant XHB1 was grown in the absence of thiostrepton, sporulated, and screened for loss of resistance as a consequence of doublecrossover events. Three thiostrepton-sensitive mutants, named XHB11, XHB12 and XHB13, were further examined. Chromosomal DNA from S. roseochromogenes wild-type as well as from mutants XHB1, XHB11, XHB12 and XHB13 was digested by PstI/PvuII and hybridized with a probe of 880 bp containing sequences of cloM and cloN1. A band at 3?33 kb was detected in the S. roseochromogenes wild-type, while chromosomal DNA from strain XHB12 showed the expected band of 2?35 kb corresponding to the in-frame deletion of cloN2. Strains XHB11 and XHB13 gave the same band of 3?33 kb as the wild-type (Fig. 2) .
Complementation of the cloN2 mutant with the cloN2 gene.
For the complementation with cloN2, vector pN2C was constructed. A fragment of 1152 bp containing the whole sequence of cloN2 (bp 21090-22242 in sequence AF329398) was obtained by PCR amplification with primer pair cloN2C/BamHI (59-CTA TCG CGG ATC CTG TTC TGC GA-39) and cloN2C/PstI (59-TAG ACC TGC AGT TGC TGC TGT G-39) using cosmid K1F2 as template. The purified PCR product was cloned into the vector pGEM-T, to give pN2C-T. The BamHI-SpeI fragment of 1?2 kb from pN2C-T was religated into the restriction sites of BamHI and XbaI of pUWL201 (Steffensky et al., 2000) . The resulting vector pN2C, containing a thiostrepton-resistance gene for selection in Streptomyces, was used for complementation of the cloN2 mutant.
Vector pN2C was introduced into the cloN2 mutant using PEGmediated protoplast transformation, as described above. After transformation, thiopstrepton-resistant clones were selected. To confirm the presence of the intact vector pN2C, plasmid was reisolated and controlled by restriction digestion and agarose gel electrophoresis.
Analysis of secondary metabolites in S. roseochromogenes strains. Wild-type and mutant strains of S. roseochromogenes were cultured in production medium (Mancy et al., 1974; Pojer et al., 2002) for 8-10 days at 33 uC, 210 r.p.m. A 20 ml sample of the whole culture was acidified with 1 M HCl to pH 2-4, and extracted twice with an equal volume of ethyl acetate. The solvent of the organic phase was removed and the residue was dissolved in 1 ml ethanol. This solution was used for HPLC and HPLC/MS analysis.
HPLC analysis was carried out on a Multosphere RP18-5 column (5 mm, 25064 mm). For analysis of aminocoumarin derivates, a linear gradient from 60 to 100 % methanol in 1 % aqueous formic acid over 20 min was used; UV detection was carried out at 340 nm. Authentic clorobiocin (Aventis) was used as standard. For analysis of pyrrole-2-carboxylic acid, an isocratic elution with 20 % methanol in 1 % aqueous formic acid was used; UV detection was carried out at 262 nm. Pyrrole-2-carboxylic acid (Lancaster, Lancashire, UK) was used as standard.
For preparative isolation of the secondary metabolites, the fractions after HPLC analysis were collected and the solvent was evaporated under vacuum. The residues were subjected to MS and NMR ( 1 H and 13 C) analysis.
Negative fast-atom bombardment (FAB) mass spectra were recorded on a TSQ70 spectrometer (Finnigan) using methanol as the solvent. LC-MS analysis and selected reaction monitoring. LC-MS was used to identify the presence of pyrrolecarboxylic acids in the culture extracts of wild-type and cloN2 mutant. Negative electrospray ionization (ESI) mass spectra were obtained from a ThermoFinnigan TSQ Quantum instrument (electrospray voltage 3 kV; heated capillary temperature 300 uC; sheath and auxiliary gas: nitrogen) equipped with a Nucleosil RP18-column (5 mm, 26250 mm, MachereyNagel) under basic conditions achieved by adding ammonia (15 ml min 21 ). For separation a gradient system of H 2 O/CH 3 CN (each containing 0?1 % HCOOH) ranging from 95 : 5 to 40 : 60 over 40 min, then to 100 % CH 3 CN over 7 min, followed by elution with 100 % CH 3 CN for 5 min, was used; flow rate 0?2 ml min 
RESULTS

Sequence analysis of cloN2
Upstream of the genes cloN3, cloN4 and cloN5, which are expected to encode enzymes for the conversion of L-proline to pyrrole-2-carboxyl-S-PCP, the gene cloN2 is located in the clorobiocin biosynthetic cluster. A homologous gene, couN2, is located at the same relative position in the coumermycin A 1 biosynthetic cluster (Pojer et al., 2002) .
Database searches revealed that cloN2 shows sequence similarity to genes contained in the biosynthetic gene clusters of certain antibiotics and antitumour agents, e.g. calO4 of the calicheamicin biosynthetic gene cluster in Micromonospora echinospora subsp. calichensis (47 % identity at the amino acid level) (Ahlert et al., 2002) , aviN of the avilamycin A cluster in Streptomyces viridochromogenes (45 % identity) (Weitnauer et al., 2001 ) and evrI of the evernimicin cluster in Micromonospora carbonacea var. africana ATCC 39149 (44 % identity) (Hosted et al., 2001) . cloN2 also shows 38 % identity (amino acid level) to dpsC of the daunorubicin/doxorubicin cluster in Streptomyces peuceticus (Grimm et al., 1994) . DpsC was shown to catalyse the transfer of propionate to an acyl carrier protein in daunorubicin biosynthesis (Bao et al., 1999a, b) . CalO4, AviN and EvrI were proposed to be involved in orsellenic acid biosynthesis and to control the nature of the starter unit of the biosynthesis (Ahlert et al., 2002; Weitnauer et al., 2001 ), but no experimental evidence has been yet published for the function of these enzymes.
By comparison of the structures of calicheamicin, avilamycin A and evernimicin with those of clorobiocin and coumermycin A 1 , it is notable that all these compounds contain one or two aromatic acyl moieties attached to a deoxysugar by an ester bond. In the cases of calicheamicin, avilamycin A and evernimicin, the acyl components are orsellenic acid derivatives and in the cases of clorobiocin and coumermycin A 1 , the acyl component is 5-methylpyrrole-2-carboxylic acid. We speculated that CloN2, and possibly CalO4, AviN and EvrI, may be involved in the transfer of the acyl component to the sugar moiety. To provide evidence for our hypothesis, we decided to inactivate cloN2 in the clorobiocin gene cluster.
Inactivation of cloN2 in S. roseochromogenes var. oscitans DS 12.976
For inactivation of cloN2 by in-frame deletion, plasmid pN2 was constructed by cloning two PCR fragments into the vector pBSKT, a pBluescript derivative containing a thiostrepton-resistance marker. Thereby, 978 bp were deleted from the coding sequence of cloN2, shortening the predicted gene product from 355 to 29 amino acids ( Fig. 2A) .
pN2 was introduced into the clorobiocin producer S. roseochromogenes var. oscitans DS 12.976 by protoplast transformation. After appropriate selection procedures (see Methods), three antibiotic-sensitive strains resulting from double-crossover events were obtained. Southern blot examination (Fig. 2B ) revealed that one of them (strain XHB12) represented the desired genotype with the inactivated cloN2 gene, while the other two (strains XHB11 und XHB13) had reverted to the wild-type.
The absence of the intact cloN2 gene and the presence of the disrupted gene were also confirmed by PCR, using primers cloN2-1/XbaI and cloN2-2/HindIII (see Methods; data not shown).
Analysis of secondary metabolites and identification of novclobiocin 104 and 105
For analysis of secondary metabolites, both wild-type and the cloN2 mutant XHB12 were cultured in production medium as described previously (Mancy et al., 1974; Pojer et al., 2002) . Ethyl acetate extracts of the cultures were analysed by HPLC with UV detection at 340 nm. The wildtype strain showed clorobiocin with a retention time of 20?9 min as the dominant product (Fig. 3A) , which was identified by co-chromatography with an authentic reference substance as well as by LC-MS (M r 696).
By contrast, the cloN2 mutant accumulated, instead of clorobiocin, two new products, with retention times of 15?5 min and 18?2 min (Fig. 3B) (Table 1) . Furthermore, the absence of the signals for carbons C-790, C-290, C-390, C-490, C-590, C-690 in the 13 C-NMR spectrum of novclobiocin 104 also confirmed the lack of the pyrrole unit in its structure (Table 1) . This proved that novclobiocin 104 is a clorobiocin derivative lacking the 5-methylpyrrole-2-carboxyl moiety at the 30 position of the deoxysugar (Fig. 1B) .
The mass spectrum of novclobiocin 105 showed a negative ion at m/z 574 (M-H) 2 , 14 mass units less than that of novclobiocin 104, indicating the lack of a methyl group. The signals at 3?59 p.p.m. in the 1 H-NMR spectrum and at 62?3 p.p.m. in the 13 C-NMR spectrum of novclobiocin 104, corresponding to the methoxy group at 40 of the deoxysugar, were not found in the corresponding spectra of novclobiocin 105. The other signals in the spectra of both compounds corresponded to each other very well (Table 1) . Obviously, both the 30 and 40 of the deoxysugar in novclobiocin 105 were not substituted (Fig. 1C) .
The amount of novclobiocin 104 and 105 produced by the cloN2 mutant was, in total, about 100-180 mg l 
H-NMR and LC/MS
Culture extracts of both the wild-type and the cloN2 mutant XHB12 of S. roseochromogenes were further analysed for free pyrrole-2-carboxylic acid by LC-MS using selected reaction monitoring (SRM). In SRM, authentic pyrrole-2-carboxylic acid gave the reaction of m/z 110Rm/z 66, corresponding to the decarboxylation of
. This reaction was observed in the wild-type as well as in the cloN2 mutant XHB12 (Fig. 4) , demonstrating the presence of pyrrole-2-carboxylic acid in both cultures. The biosynthesis of the pyrrole moiety in the cloN2 mutant was therefore not blocked.
The presence of pyrrole-2-carboxylic acid in the cloN2 mutant was further confirmed by 1 H-NMR analysis. The pyrrole-2-carboxylic acid (retention time 7?7 min) was isolated from the culture extract on a preparative scale and analysed by 1 H-NMR. The spectrum showed three doubletdoublet signals, at 6?93, 6?84 and 6?17 p.p.m., which were identical to those of authentic pyrrole-2-carboxylic acid and consistent with the literature data (Shimokawa et al., 1970) . The amount of pyrrole-2-carboxylic acid accumulated in the cloN2 mutant was about 1?2 mg l 21 (corresponding to 11 mmol l
21
). Comparable amounts of this substance were found in the wild-type.
The ethyl acetate extracts of the cultures were also used to investigate the presence of 5-methylpyrrole-2-carboxylic acid (M r 125) by LC-MS with SRM. Using SRM, the reaction of m/z 124Rm/z 80, representing the decarboxylation 
of [M-H]
2
, was observed in the wild-type, but not in the cloN2 mutant (Fig. 4) , which indicated the complete absence of 5-methylpyrrole-2-carboxylic acid in the cloN2 mutant.
Complementation of the cloN2 mutant with pN2C
To complement the cloN2 mutant XHB12, a vector pN2C was constructed, containing the entire sequence of cloN2 in pUWL201 under the control of the constitutive ermE*p promoter. HPLC analysis showed that the cloN2 mutant harbouring plasmid pN2C (strain XHBC12) produced clorobiocin in an amount similar to the wild-type (Fig. 3C) . At the same time, this strain still produced considerable amounts of novclobiocin 104 and 105. No clorobiocin production was detected in transformants with empty vector pUWL201 (data not shown).
DISCUSSION
In the clorobiocin producer S. roseochromogenes, inactivation of the gene cloN2 by in-frame deletion resulted in the accumulation of two new aminocoumarin derivatives, novclobiocin 104 and 105, both lacking the pyrrole moiety at C-30 of the deoxysugar. However, free pyrrole-2-carboxylic acid was still produced by the cloN2 mutant, proving that the mutation did not affect the biosynthesis of this moiety, but rather its transfer to the deoxysugar unit of clorobiocin. Clorobiocin production could be restored by expression of cloN2 in the cloN2 mutant, which demonstrates that only the cloN2 gene had been inactivated. Our results prove that CloN2 is involved in the formation of the ester bond between the pyrrole-2-carboxylic acid moiety and the deoxysugar. Most likely, CloN2 transfers the acyl moiety from a pyrrole-2-carboxyl-S-CloN5 intermediate to the 3-OH of the deoxysugar moiety of clorobiocin (see Fig. 5 )
The same function may be postulated for the corresponding gene of the coumermycin biosynthetic gene cluster, i.e. couN2. CouN2 shows 86 % identity to CloN2, and both proteins comprise 355 amino acids.
Genes with sequence similarity to cloN2, i.e. calO4, aviN and evrI, are also found in the biosynthetic clusters of calicheamicin (Ahlert et al., 2002) , avilamycin A (Weitnauer et al., 2001 ) and evernimicin (Hosted et al., 2001) , respectively. It has been proposed that they may control the starter unit for orsellenic acid biosynthesis, based on their sequence similarity to dpsC (Hosted et al., 2001; Weitnauer et al., 2001) . However, their function has not been proven experimentally. All three compounds (calicheamicin, avilamycin and evernimicin) contain an orsellinic acid unit attached via an ester bond to a deoxysugar moiety. Since we have now provided evidence that cloN2 is involved in the acyl transfer of an aromatic carboxylic acid to the deoxysugar moiety of clorobiocin, it should be considered whether also CalO4, AviN and EvrI may be responsible for the acylation of the deoxysugar moieties of the respective antibiotics.
In our experiments, only pyrrole-2-carboxylic acid, but not its 5-methyl derivative, was found in the cloN2 mutant.
This indicates that the methylation of the pyrrole unit occurs only after its transfer to the deoxysugar moiety (Fig. 5) . The wild-type contained a small quantity of free 5-methylpyrrole-2-carboxylic acid, possibly produced by hydrolysis of clorobiocin. This compound was not found in the cloN2 mutant, which is consistent with the above hypothesis.
A clorobiocin derivative lacking the methyl group at the pyrrole moiety (designated as antibiotic 2562 B) has been isolated previously from Streptomyces griseovariabilis (Lysenkova et al., 1980) . Similarly, coumermycin derivates lacking the methyl group at C-5 of one or both the pyrrole-2-carboxylic acid moieties have been identified in the coumermycin producer (Claridge et al., 1984) .
Both in the clorobiocin and in the coumermycin A 1 gene cluster, a contiguous group of seven genes is found (cloN1-cloN7 and couN1-couN7, respectively), which are absent in the biosynthetic gene cluster of novobiocin (Pojer et al., 2002) . These genes show high homology between the clorobiocin and the coumermycin cluster (average 87 % identity at the amino acid level). CloN3, CloN4 and CloN5 and the corresponding CouN3, CouN4 and CouN5 are expected to catalyse the conversion of L-proline to pyrrole-2-carboxyl-S-PCP (see Fig. 5 ) (Thomas et al., 2002; Xu et al., 2002) . CloN6/CouN6 may catalyse the C-methylation at position 5 of the pyrrole-2-carboxyl moieties (Pojer et al., 2002) . CloN2 is involved in the acyl transfer to the deoxysugar moiety, as shown in this study. Therefore, only the roles of the small ORF cloN1 and the putative hydrolase gene cloN7 are as yet unclear. Inactivation of these genes may provide evidence of their importance for the biosynthesis of aminocoumarin antibiotics. 01EC0001. H. Xu received a graduate student scholarship from Bundesland Baden-Wuerttemberg, Germany. 
